Nuwellis Inc (NUWE)

Currency in USD
1.310
+0.010(+0.77%)
Closed·
1.3100.000(0.00%)
·
NUWE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.3001.370
52 wk Range
1.250235.200
Key Statistics
Prev. Close
1.3
Open
1.32
Day's Range
1.3-1.37
52 wk Range
1.25-235.2
Volume
274.89K
Average Volume (3m)
2.95M
1-Year Change
-99.3364%
Book Value / Share
40.31
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NUWE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Nuwellis Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.000

Nuwellis Inc Earnings Call Summary for Q2/2026

  • Q2 revenue rose 14% YoY to $1.97M; gross margin jumped to 76% from 56%; net loss narrowed 62% to $4.8M from $12.6M.
  • Console placements tripled to 9 units from 3 YoY; company raised $12.7M in June-July financing, ending quarter with $3.9M cash, no debt.
  • Shares fell 3.55% to $1.36 post-earnings despite improvements, reflecting investor caution over continued losses and small revenue base.
  • Plans Q4 2026 FDA filing for pediatric label expansion (5kg+ vs 20kg+); targeting 2027 launch of Clarity Prime kidney monitoring system.
  • No formal guidance issued; priorities include boosting recurring circuit revenue, maintaining margin discipline, reducing cash burn.
Last Updated: 08/13/2026, 10:06 PM
Read Full Transcript

Earnings

Latest Release
May 12, 2026
EPS / Forecast
-2.09 / --
Revenue / Forecast
2.4M / 2.09M
EPS Revisions
Last 90 days

NUWE Income Statement

Compare NUWE to Peers and Sector

Metrics to compare
NUWE
Peers
Sector
Relationship
P/E Ratio
−0.2x−2.8x−0.4x
PEG Ratio
-−0.100.00
Price/Book
1.6x2.6x2.6x
Price / LTM Sales
0.5x2.4x3.1x
Upside (Analyst Target)
-81.0%48.4%
Fair Value Upside
Unlock−3.6%6.5%Unlock

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.11K0.76%1.57K
Other Institutional Investors
256.23K99.24%361.29K
Public Companies & Retail Investors
0.000.00%0.00
Total
257.34K100.00%362.85K

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Lind Partners, LLC131.70%193,050272
Armistice Capital LLC20.57%30,15743

People Also Watch

0.7410
HUBC
-1.29%
140.00
SPCX
-0.91%
4.8400
MNTS
-1.43%
3.110
HKIT
+2.64%

FAQ

What Is the Nuwellis (NUWE) Stock Price Today?

The Nuwellis stock price today is 1.310 USD.

What Stock Exchange Does Nuwellis Trade On?

Nuwellis is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Nuwellis?

The stock symbol for Nuwellis is "NUWE."

What Is the Nuwellis Market Cap?

As of today, Nuwellis market cap is 4.180M USD.

What Is Nuwellis's Earnings Per Share (TTM)?

The Nuwellis EPS (TTM) is -563.486.

From a Technical Analysis Perspective, Is NUWE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nuwellis Stock Split?

Nuwellis has split 12 times.

How Many Employees Does Nuwellis Have?

Nuwellis has 38 employees.

What is the current trading status of Nuwellis (NUWE)?

As of Aug 14, 2026, Nuwellis (NUWE) is trading at a price of 1.310 USD, with a previous close of 1.300 USD. The stock has fluctuated within a day range of 1.300 USD to 1.370 USD, while its 52-week range spans from 1.250 USD to 235.200 USD.

What Is the NUWE Premarket Price?

NUWE's last pre-market stock price is 1.320 USD. The pre-market share volume is 51,110.000, and the stock has decreased by 0.020, or 1.540%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.